
Snoglo 250mg Tablet
Marketer
Tas Med India Pvt Ltd
Salt Composition
Tranexamic Acid (250mg)
Overview Snoglo 250mg Tablet
Hemostatic tablets, Snoglo 250mg, effectively manage hemorrhaging. Their application encompasses various scenarios including dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and procedures involving the oral cavity, prostate, or bladder. Classified as an antifibrinolytic, Snoglo 250mg functions by inhibiting clot dissolution, thus controlling blood loss. Adherence to the prescribed dosage and duration is crucial. Pre-existing allergies to this medication necessitate avoidance. Fatigue and musculoskeletal pain are commonly reported side effects. Disclosure of prior cardiac surgery or kidney impairment is essential. Snoglo 250mg is deemed safe for use during pregnancy and lactation, and in individuals with liver disease. Alcohol consumption post-administration should be avoided due to the potential for increased somnolence.
Uses of Snoglo 250mg Tablet
Managing Hemorrhage
Major Benefits of Snoglo 250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Snoglo 250mg Tablet should be administered with a meal.
Common Side effects of Snoglo 250mg Tablet:
- Musculoskeletal (bone, muscle or joint) pain
- Joint pain
- Headache
- Back pain
- Vomiting
- Nausea
- Abdominal pain
- Fatigue
- Diarrhea
- Hypotension (low blood pressure)
- Sinus disorder
- Anemia (low number of red blood cells)
- Allergic dermatitis
- Lightheadedness
- Thromboembolism
How to use Snoglo 250mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. The Snoglo 250mg Tablet should be administered with a meal.
How Snoglo 250mg Tablet works:
Hemostatic agent Snoglo 250mg tablets inhibit fibrinolysis, thus preventing clot dissolution and managing excessive menstrual or post-surgical hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Snoglo 250mg tablets and alcohol may induce significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Snoglo 250mg Tablet use in pregnancy is lacking. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Snoglo 250mg tablets while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Snoglo 250mg Tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Snoglo 250mg Tablets. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Snoglo 250mg tablets in patients with liver disease is likely safe. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Snoglo 250mg Tablet :
Omit any missed Snoglo 250mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Snoglo 250mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
